+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Non-Invasive Prenatal DNA Testing Service Market - Global Forecast 2026-2032- Product Image
Non-Invasive Prenatal DNA Testing Service Market - Global Forecast 2026-2032- Product Image
Sale

Non-Invasive Prenatal DNA Testing Service Market - Global Forecast 2026-2032

  • Report

  • 196 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6140264
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Non-Invasive Prenatal DNA Testing Service Market is projected to reach USD 5.97 Billion in 2026. It is expected to continue growing at a CAGR of 12.89%, reaching USD 12.58 Billion by 2032.

Introduction to Non-Invasive Prenatal DNA Testing Services

Non-invasive prenatal DNA testing (NIPT) services analyze fetal genetic material circulating in maternal blood, typically to screen for selected chromosomal conditions. The service ecosystem includes clinical consultation, blood collection, laboratory analysis, bioinformatics, result interpretation, and follow-up diagnostic pathways. NIPT is a screening tool rather than a definitive diagnosis, so positive or uncertain findings generally require counseling and confirmatory diagnostic testing.

Transformative Shifts Reshaping Prenatal Genetic Screening

The landscape is shifting toward earlier, more accessible, and more integrated prenatal screening. Improvements in sequencing, laboratory automation, quality controls, and digital reporting are supporting broader clinical use, while professional guidance increasingly emphasizes informed consent, appropriate test selection, and clear communication of limitations. Adoption is also being shaped by reimbursement rules, public-health programs, laboratory accreditation, turnaround-time expectations, and concerns about equitable access and the handling of incidental findings.

How Artificial Intelligence Is Changing Testing Workflows

Artificial intelligence is being applied across sample-quality assessment, sequencing-data interpretation, anomaly detection, workflow automation, and patient-facing communication. These tools may help identify low-quality samples, prioritize laboratory review, and improve consistency in reporting, but their clinical value depends on representative validation data, transparent performance metrics, human oversight, and strong cybersecurity. AI should support-not replace-qualified clinicians and genetic counselors, particularly when results are ambiguous or may influence significant reproductive decisions.

Regional Insights Across Six Diverse Healthcare Environments

North America is characterized by established laboratory infrastructure, specialist care pathways, and active debate over reimbursement, consent, and regulatory oversight. Europe combines advanced healthcare systems with varied national coverage policies and stringent data-protection expectations. Asia-Pacific includes technologically capable markets alongside substantial differences in access, regulation, and clinical capacity. Latin America is shaped by uneven laboratory availability, private-sector provision, and the need for affordable referral networks. The Middle East shows growing interest in genomic medicine within systems where religious, legal, and national screening considerations can influence service design. Africa faces wider disparities in laboratory capacity, specialist counseling, and affordability, making partnerships, quality assurance, and locally appropriate referral models particularly important.

Group Insights: ASEAN, BRICS, EU, G7, GCC, and NATO

ASEAN members present a mixed environment in which urban specialist centers may offer advanced testing while access remains uneven across and within countries. BRICS economies combine substantial scientific capabilities with differing regulatory, reimbursement, and public-health priorities. The European Union emphasizes cross-border data governance, laboratory quality, and nationally determined healthcare pathways. G7 systems generally have mature clinical infrastructure but continue to address affordability, equitable access, and responsible communication of uncertain findings. GCC countries are investing in genomic-health capabilities while aligning services with local policy and cultural expectations. NATO members span diverse health systems, so common security and research interests do not eliminate national differences in prenatal screening practice.

Country Insights: Diverse Regulatory and Clinical Contexts

Australia and Canada combine advanced healthcare systems with geographically dispersed populations, making referral access and reimbursement important considerations. The United States has broad laboratory availability but variable coverage, provider practice, and counseling pathways. Brazil and Mexico show expanding private and specialist capacity alongside unequal access between major cities and underserved areas. China, India, Japan, and South Korea have strong technical capabilities, while policy, clinical adoption, and access differ by jurisdiction and care setting. France, Germany, Italy, Spain, and the United Kingdom operate within established European clinical frameworks, with national guidance, public coverage decisions, and data governance shaping use. Russia’s service environment is influenced by domestic laboratory capacity, healthcare policy, and access to specialized follow-up. Across all countries, reliable confirmatory testing and qualified counseling remain essential to safe implementation.

Actions for Leaders: Build Trust, Quality, and Equitable Access

Industry leaders should position NIPT as part of a complete clinical pathway rather than as a standalone laboratory result. Priorities include validating assays across relevant populations, maintaining accreditation and external quality assessment, publishing clinically meaningful performance information, and providing plain-language consent materials. Organizations should establish explicit protocols for inadequate samples, incidental findings, positive screens, and confirmatory referrals. Responsible AI governance should include bias testing, audit trails, privacy safeguards, and clinician review. Leaders can also improve access through tiered service models, partnerships with public providers, remote counseling, workforce training, and transparent patient-support policies that avoid overstating what screening can determine.

Research Methodology for the Executive Summary

This summary uses the supplied market definition-non-invasive prenatal DNA testing services-and synthesizes established clinical, technological, regulatory, and healthcare-delivery considerations. The analysis distinguishes screening from diagnosis and avoids numerical market estimates, forecasts, market shares, and company-specific claims. Regional, group, and country discussions are comparative and qualitative, reflecting differences in infrastructure, policy, reimbursement, laboratory capability, data governance, and access. Interpretations should be reviewed against current national guidelines, regulatory decisions, reimbursement policies, and peer-reviewed clinical evidence before operational or clinical use.

Conclusion: Scale NIPT Through Clinically Responsible Integration

Non-invasive prenatal DNA testing services are most sustainable when embedded in a coordinated pathway that includes informed choice, rigorous laboratory quality, qualified interpretation, and accessible confirmatory care. Regional and national conditions will continue to shape implementation, while AI can improve operational consistency if deployed with validation, transparency, and human accountability. The central leadership opportunity is to expand appropriate access without weakening clinical safeguards, privacy protections, or the distinction between a screening result and a diagnosis.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Non-Invasive Prenatal DNA Testing Service Market, by Technology
7.1. Introduction
7.2. Digital PCR
7.2.1. BEAMing
7.2.2. Droplet Digital PCR
7.3. Microarray
7.3.1. Array Comparative Genomic Hybridization
7.3.2. SNP Microarray
7.4. Next-Generation Sequencing
7.4.1. Single-Nucleotide Polymorphism Sequencing
7.4.2. Targeted Sequencing
7.4.3. Whole-Genome Sequencing
8. Non-Invasive Prenatal DNA Testing Service Market, by Service Model
8.1. Introduction
8.2. Centralized
8.2.1. Contract Laboratories
8.2.2. Reference Laboratories
8.3. Decentralized
8.3.1. Clinic-Based Laboratories
8.3.2. Hospital Laboratories
9. Non-Invasive Prenatal DNA Testing Service Market, by Sample Type
9.1. Introduction
9.2. Dried Blood Spot
9.3. Maternal Plasma
9.4. Urine
10. Non-Invasive Prenatal DNA Testing Service Market, by Application
10.1. Introduction
10.2. Microdeletion Syndrome
10.2.1. 1p36 Deletion Syndrome
10.2.2. 22q11 Deletion Syndrome
10.3. Sex Chromosome Abnormality
10.3.1. Klinefelter Syndrome
10.3.2. Turner Syndrome
10.4. Trisomy Detection
10.4.1. Down Syndrome
10.4.2. Edwards Syndrome
10.4.3. Patau Syndrome
11. Non-Invasive Prenatal DNA Testing Service Market, by End User
11.1. Introduction
11.2. Clinics
11.3. Diagnostic Laboratories
11.4. Hospitals
12. Non-Invasive Prenatal DNA Testing Service Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Non-Invasive Prenatal DNA Testing Service Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Non-Invasive Prenatal DNA Testing Service Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Agile Bio
16.2. ARUP Laboratories, LLC
16.3. Bio-Reference Laboratories, Inc.
16.4. Biora Labs Pvt. Ltd.
16.5. BMLabs
16.6. Centogene N.V.
16.7. Cohesion Healthcare Services, Inc.
16.8. Eurofins LifeCodexx GmbH
16.9. Freenome Holdings, Inc.
16.10. Fulgent Genetics, Inc.
16.11. Genedia Co., Ltd.
16.12. GenePlanet d.o.o.
16.13. Genetics Institute, LLC
16.14. Genoma S.A.
16.15. Health Network Laboratories, Inc.
16.16. Illumina, Inc.
16.17. Integrated Genetics, LLC
16.18. Invitae Corporation
16.19. Laboratory Corporation of America Holdings
16.20. Natera, Inc.
16.21. PerkinElmer, Inc.
16.22. Progenity, Inc.
16.23. Quest Diagnostics Incorporated
16.24. Roche Holding AG
16.25. Sema4, Inc.
16.26. Shenzhen BGI Gene-Tech Co., Ltd.
16.27. Sonic Healthcare Limited
16.28. Thermo Fisher Scientific Inc.
16.29. Trivitron Healthcare Pvt. Ltd.
16.30. Yourgene Health plc
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global Non-Invasive Prenatal DNA Testing Service Market, Years Considered for the Study
FIGURE 2. Global Non-Invasive Prenatal DNA Testing Service Market, Research Design
FIGURE 3. Global Non-Invasive Prenatal DNA Testing Service Market, Research Framework
FIGURE 4. Global Non-Invasive Prenatal DNA Testing Service Market, Data Triangulation
FIGURE 5. Global Non-Invasive Prenatal DNA Testing Service Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Non-Invasive Prenatal DNA Testing Service Market Size, by Technology, 2025 vs 2032 (%)
FIGURE 7. Global Non-Invasive Prenatal DNA Testing Service Market Size, by Technology, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Non-Invasive Prenatal DNA Testing Service Market Size, by Service Model, 2025 vs 2032 (%)
FIGURE 9. Global Non-Invasive Prenatal DNA Testing Service Market Size, by Service Model, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Non-Invasive Prenatal DNA Testing Service Market Size, by Sample Type, 2025 vs 2032 (%)
FIGURE 11. Global Non-Invasive Prenatal DNA Testing Service Market Size, by Sample Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Non-Invasive Prenatal DNA Testing Service Market Size, by Application, 2025 vs 2032 (%)
FIGURE 13. Global Non-Invasive Prenatal DNA Testing Service Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Non-Invasive Prenatal DNA Testing Service Market Size, by End User, 2025 vs 2032 (%)
FIGURE 15. Global Non-Invasive Prenatal DNA Testing Service Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Non-Invasive Prenatal DNA Testing Service Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Non-Invasive Prenatal DNA Testing Service Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Non-Invasive Prenatal DNA Testing Service Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Non-Invasive Prenatal DNA Testing Service Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Non-Invasive Prenatal DNA Testing Service Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Non-Invasive Prenatal DNA Testing Service Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Non-Invasive Prenatal DNA Testing Service Market Segmentation & Coverage
TABLE 2. Global Non-Invasive Prenatal DNA Testing Service Market Size, 2017-2032 (USD Million)
TABLE 3. Global Non-Invasive Prenatal DNA Testing Service Market Size, by Technology, 2017-2032 (USD Million)
TABLE 4. Global Digital PCR Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Digital PCR Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Digital PCR Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global BEAMing Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global BEAMing Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global BEAMing Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Droplet Digital PCR Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Droplet Digital PCR Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Droplet Digital PCR Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Microarray Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Microarray Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Microarray Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Array Comparative Genomic Hybridization Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Array Comparative Genomic Hybridization Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Array Comparative Genomic Hybridization Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global SNP Microarray Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global SNP Microarray Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global SNP Microarray Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Next-Generation Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Next-Generation Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Next-Generation Sequencing Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Single-Nucleotide Polymorphism Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Single-Nucleotide Polymorphism Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Single-Nucleotide Polymorphism Sequencing Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Targeted Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Targeted Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Targeted Sequencing Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Whole-Genome Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Whole-Genome Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Whole-Genome Sequencing Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Non-Invasive Prenatal DNA Testing Service Market Size, by Service Model, 2017-2032 (USD Million)
TABLE 35. Global Centralized Market Size, by Region, 2017-2032 (USD Million)
TABLE 36. Global Centralized Market Size, by Group, 2017-2032 (USD Million)
TABLE 37. Global Centralized Market Size, by Country, 2017-2032 (USD Million)
TABLE 38. Global Contract Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 39. Global Contract Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 40. Global Contract Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 41. Global Reference Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 42. Global Reference Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 43. Global Reference Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 44. Global Decentralized Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global Decentralized Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global Decentralized Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global Clinic-Based Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global Clinic-Based Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global Clinic-Based Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global Hospital Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Global Hospital Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 52. Global Hospital Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 53. Global Non-Invasive Prenatal DNA Testing Service Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 54. Global Dried Blood Spot Market Size, by Region, 2017-2032 (USD Million)
TABLE 55. Global Dried Blood Spot Market Size, by Group, 2017-2032 (USD Million)
TABLE 56. Global Dried Blood Spot Market Size, by Country, 2017-2032 (USD Million)
TABLE 57. Global Maternal Plasma Market Size, by Region, 2017-2032 (USD Million)
TABLE 58. Global Maternal Plasma Market Size, by Group, 2017-2032 (USD Million)
TABLE 59. Global Maternal Plasma Market Size, by Country, 2017-2032 (USD Million)
TABLE 60. Global Urine Market Size, by Region, 2017-2032 (USD Million)
TABLE 61. Global Urine Market Size, by Group, 2017-2032 (USD Million)
TABLE 62. Global Urine Market Size, by Country, 2017-2032 (USD Million)
TABLE 63. Global Non-Invasive Prenatal DNA Testing Service Market Size, by Application, 2017-2032 (USD Million)
TABLE 64. Global Microdeletion Syndrome Market Size, by Region, 2017-2032 (USD Million)
TABLE 65. Global Microdeletion Syndrome Market Size, by Group, 2017-2032 (USD Million)
TABLE 66. Global Microdeletion Syndrome Market Size, by Country, 2017-2032 (USD Million)
TABLE 67. Global 1p36 Deletion Syndrome Market Size, by Region, 2017-2032 (USD Million)
TABLE 68. Global 1p36 Deletion Syndrome Market Size, by Group, 2017-2032 (USD Million)
TABLE 69. Global 1p36 Deletion Syndrome Market Size, by Country, 2017-2032 (USD Million)
TABLE 70. Global 22q11 Deletion Syndrome Market Size, by Region, 2017-2032 (USD Million)
TABLE 71. Global 22q11 Deletion Syndrome Market Size, by Group, 2017-2032 (USD Million)
TABLE 72. Global 22q11 Deletion Syndrome Market Size, by Country, 2017-2032 (USD Million)
TABLE 73. Global Sex Chromosome Abnormality Market Size, by Region, 2017-2032 (USD Million)
TABLE 74. Global Sex Chromosome Abnormality Market Size, by Group, 2017-2032 (USD Million)
TABLE 75. Global Sex Chromosome Abnormality Market Size, by Country, 2017-2032 (USD Million)
TABLE 76. Global Klinefelter Syndrome Market Size, by Region, 2017-2032 (USD Million)
TABLE 77. Global Klinefelter Syndrome Market Size, by Group, 2017-2032 (USD Million)
TABLE 78. Global Klinefelter Syndrome Market Size, by Country, 2017-2032 (USD Million)
TABLE 79. Global Turner Syndrome Market Size, by Region, 2017-2032 (USD Million)
TABLE 80. Global Turner Syndrome Market Size, by Group, 2017-2032 (USD Million)
TABLE 81. Global Turner Syndrome Market Size, by Country, 2017-2032 (USD Million)
TABLE 82. Global Trisomy Detection Market Size, by Region, 2017-2032 (USD Million)
TABLE 83. Global Trisomy Detection Market Size, by Group, 2017-2032 (USD Million)
TABLE 84. Global Trisomy Detection Market Size, by Country, 2017-2032 (USD Million)
TABLE 85. Global Down Syndrome Market Size, by Region, 2017-2032 (USD Million)
TABLE 86. Global Down Syndrome Market Size, by Group, 2017-2032 (USD Million)
TABLE 87. Global Down Syndrome Market Size, by Country, 2017-2032 (USD Million)
TABLE 88. Global Edwards Syndrome Market Size, by Region, 2017-2032 (USD Million)
TABLE 89. Global Edwards Syndrome Market Size, by Group, 2017-2032 (USD Million)
TABLE 90. Global Edwards Syndrome Market Size, by Country, 2017-2032 (USD Million)
TABLE 91. Global Patau Syndrome Market Size, by Region, 2017-2032 (USD Million)
TABLE 92. Global Patau Syndrome Market Size, by Group, 2017-2032 (USD Million)
TABLE 93. Global Patau Syndrome Market Size, by Country, 2017-2032 (USD Million)
TABLE 94. Global Non-Invasive Prenatal DNA Testing Service Market Size, by End User, 2017-2032 (USD Million)
TABLE 95. Global Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 96. Global Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 97. Global Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 98. Global Diagnostic Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 99. Global Diagnostic Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 100. Global Diagnostic Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 101. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 102. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 103. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 104. Global Non-Invasive Prenatal DNA Testing Service Market Size, by Region, 2017-2032 (USD Million)
TABLE 105. Asia-Pacific Non-Invasive Prenatal DNA Testing Service Market Size, by Region, 2017-2032 (USD Million)
TABLE 106. Asia-Pacific Non-Invasive Prenatal DNA Testing Service Market Size, by Technology, 2017-2032 (USD Million)
TABLE 107. Asia-Pacific Non-Invasive Prenatal DNA Testing Service Market Size, by Digital PCR, 2017-2032 (USD Million)
TABLE 108. Asia-Pacific Non-Invasive Prenatal DNA Testing Service Market Size, by Microarray, 2017-2032 (USD Million)
TABLE 109. Asia-Pacific Non-Invasive Prenatal DNA Testing Service Market Size, by Next-Generation Sequencing, 2017-2032 (USD Million)
TABLE 110. Asia-Pacific Non-Invasive Prenatal DNA Testing Service Market Size, by Service Model, 2017-2032 (USD Million)
TABLE 111. Asia-Pacific Non-Invasive Prenatal DNA Testing Service Market Size, by Centralized, 2017-2032 (USD Million)
TABLE 112. Asia-Pacific Non-Invasive Prenatal DNA Testing Service Market Size, by Decentralized, 2017-2032 (USD Million)
TABLE 113. Asia-Pacific Non-Invasive Prenatal DNA Testing Service Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 114. Asia-Pacific Non-Invasive Prenatal DNA Testing Service Market Size, by Application, 2017-2032 (USD Million)
TABLE 115. Asia-Pacific Non-Invasive Prenatal DNA Testing Service Market Size, by Microdeletion Syndrome, 2017-2032 (USD Million)
TABLE 116. Asia-Pacific Non-Invasive Prenatal DNA Testing Service Market Size, by Sex Chromosome Abnormality, 2017-2032 (USD Million)
TABLE 117. Asia-Pacific Non-Invasive Prenatal DNA Testing Service Market Size, by Trisomy Detection, 2017-2032 (USD Million)
TABLE 118. Asia-Pacific Non-Invasive Prenatal DNA Testing Service Market Size, by End User, 2017-2032 (USD Million)
TABLE 119. North America Non-Invasive Prenatal DNA Testing Service Market Size, by Region, 2017-2032 (USD Million)
TABLE 120. North America Non-Invasive Prenatal DNA Testing Service Market Size, by Technology, 2017-2032 (USD Million)
TABLE 121. North America Non-Invasive Prenatal DNA Testing Service Market Size, by Digital PCR, 2017-2032 (USD Million)
TABLE 122. North America Non-Invasive Prenatal DNA Testing Service Market Size, by Microarray, 2017-2032 (USD Million)
TABLE 123. North America Non-Invasive Prenatal DNA Testing Service Market Size, by Next-Generation Sequencing, 2017-2032 (USD Million)
TABLE 124. North America Non-Invasive Prenatal DNA Testing Service Market Size, by Service Model, 2017-2032 (USD Million)
TABLE 125. North America Non-Invasive Prenatal DNA Testing Service Market Size, by Centralized, 2017-2032 (USD Million)
TABLE 126. North America Non-Invasive Prenatal DNA Testing Service Market Size, by Decentralized, 2017-2032 (USD Million)
TABLE 127. North America Non-Invasive Prenatal DNA Testing Service Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 128. North America Non-Invasive Prenatal DNA Testing Service Market Size, by Application, 2017-2032 (USD Million)
TABLE 129. North America Non-Invasive Prenatal DNA Testing Service Market Size, by Microdeletion Syndrome, 2017-2032 (USD Million)
TABLE 130. North America Non-Invasive Prenatal DNA Testing Service Market Size, by Sex Chromosome Abnormality, 2017-2032 (USD Million)
TABLE 131. North America Non-Invasive Prenatal DNA Testing Service Market Size, by Trisomy Detection, 2017-2032 (USD Million)
TABLE 132. North America Non-Invasive Prenatal DNA Testing Service Market Size, by End User, 2017-2032 (USD Million)
TABLE 133. Latin America Non-Invasive Prenatal DNA Testing Service Market Size, by Region, 2017-2032 (USD Million)
TABLE 134. Latin America Non-Invasive Prenatal DNA Testing Service Market Size, by Technology, 2017-2032 (USD Million)
TABLE 135. Latin America Non-Invasive Prenatal DNA Testing Service Market Size, by Digital PCR, 2017-2032 (USD Million)
TABLE 136. Latin America Non-Invasive Prenatal DNA Testing Service Market Size, by Microarray, 2017-2032 (USD Million)
TABLE 137. Latin America Non-Invasive Prenatal DNA Testing Service Market Size, by Next-Generation Sequencing, 2017-2032 (USD Million)
TABLE 138. Latin America Non-Invasive Prenatal DNA Testing Service Market Size, by Service Model, 2017-2032 (USD Million)
TABLE 139. Latin America Non-Invasive Prenatal DNA Testing Service Market Size, by Centralized, 2017-2032 (USD Million)
TABLE 140. Latin America Non-Invasive Prenatal DNA Testing Service Market Size, by Decentralized, 2017-2032 (USD Million)
TABLE 141. Latin America Non-Invasive Prenatal DNA Testing Service Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 142. Latin America Non-Invasive Prenatal DNA Testing Service Market Size, by Application, 2017-2032 (USD Million)
TABLE 143. Latin America Non-Invasive Prenatal DNA Testing Service Market Size, by Microdeletion Syndrome, 2017-2032 (USD Million)
TABLE 144. Latin America Non-Invasive Prenatal DNA Testing Service Market Size, by Sex Chromosome Abnormality, 2017-2032 (USD Million)
TABLE 145. Latin America Non-Invasive Prenatal DNA Testing Service Market Size, by Trisomy Detection, 2017-2032 (USD Million)
TABLE 146. Latin America Non-Invasive Prenatal DNA Testing Service Market Size, by End User, 2017-2032 (USD Million)
TABLE 147. Europe Non-Invasive Prenatal DNA Testing Service Market Size, by Region, 2017-2032 (USD Million)
TABLE 148. Europe Non-Invasive Prenatal DNA Testing Service Market Size, by Technology, 2017-2032 (USD Million)
TABLE 149. Europe Non-Invasive Prenatal DNA Testing Service Market Size, by Digital PCR, 2017-2032 (USD Million)
TABLE 150. Europe Non-Invasive Prenatal DNA Testing Service Market Size, by Microarray, 2017-2032 (USD Million)
TABLE 151. Europe Non-Invasive Prenatal DNA Testing Service Market Size, by Next-Generation Sequencing, 2017-2032 (USD Million)
TABLE 152. Europe Non-Invasive Prenatal DNA Testing Service Market Size, by Service Model, 2017-2032 (USD Million)
TABLE 153. Europe Non-Invasive Prenatal DNA Testing Service Market Size, by Centralized, 2017-2032 (USD Million)
TABLE 154. Europe Non-Invasive Prenatal DNA Testing Service Market Size, by Decentralized, 2017-2032 (USD Million)
TABLE 155. Europe Non-Invasive Prenatal DNA Testing Service Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 156. Europe Non-Invasive Prenatal DNA Testing Service Market Size, by Application, 2017-2032 (USD Million)
TABLE 157. Europe Non-Invasive Prenatal DNA Testing Service Market Size, by Microdeletion Syndrome, 2017-2032 (USD Million)
TABLE 158. Europe Non-Invasive Prenatal DNA Testing Service Market Size, by Sex Chromosome Abnormality, 2017-2032 (USD Million)
TABLE 159. Europe Non-Invasive Prenatal DNA Testing Service Market Size, by Trisomy Detection, 2017-2032 (USD Million)
TABLE 160. Europe Non-Invasive Prenatal DNA Testing Service Market Size, by End User, 2017-2032 (USD Million)
TABLE 161. Middle East Non-Invasive Prenatal DNA Testing Service Market Size, by Region, 2017-2032 (USD Million)
TABLE 162. Middle East Non-Invasive Prenatal DNA Testing Service Market Size, by Technology, 2017-2032 (USD Million)
TABLE 163. Middle East Non-Invasive Prenatal DNA Testing Service Market Size, by Digital PCR, 2017-2032 (USD Million)
TABLE 164. Middle East Non-Invasive Prenatal DNA Testing Service Market Size, by Microarray, 2017-2032 (USD Million)
TABLE 165. Middle East Non-Invasive Prenatal DNA Testing Service Market Size, by Next-Generation Sequencing, 2017-2032 (USD Million)
TABLE 166. Middle East Non-Invasive Prenatal DNA Testing Service Market Size, by Service Model, 2017-2032 (USD Million)
TABLE 167. Middle East Non-Invasive Prenatal DNA Testing Service Market Size, by Centralized, 2017-2032 (USD Million)
TABLE 168. Middle East Non-Invasive Prenatal DNA Testing Service Market Size, by Decentralized, 2017-2032 (USD Million)
TABLE 169. Middle East Non-Invasive Prenatal DNA Testing Service Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 170. Middle East Non-Invasive Prenatal DNA Testing Service Market Size, by Application, 2017-2032 (USD Million)
TABLE 171. Middle East Non-Invasive Prenatal DNA Testing Service Market Size, by Microdeletion Syndrome, 2017-2032 (USD Million)
TABLE 172. Middle East Non-Invasive Prenatal DNA Testing Service Market Size, by Sex Chromosome Abnormality, 2017-2032 (USD Million)
TABLE 173. Middle East Non-Invasive Prenatal DNA Testing Service Market Size, by Trisomy Detection, 2017-2032 (USD Million)
TABLE 174. Middle East Non-Invasive Prenatal DNA Testing Service Market Size, by End User, 2017-2032 (USD Million)
TABLE 175. Africa Non-Invasive Prenatal DNA Testing Service Market Size, by Region, 2017-2032 (USD Million)
TABLE 176. Africa Non-Invasive Prenatal DNA Testing Service Market Size, by Technology, 2017-2032 (USD Million)
TABLE 177. Africa Non-Invasive Prenatal DNA Testing Service Market Size, by Digital PCR, 2017-2032 (USD Million)
TABLE 178. Africa Non-Invasive Prenatal DNA Testing Service Market Size, by Microarray, 2017-2032 (USD Million)
TABLE 179. Africa Non-Invasive Prenatal DNA Testing Service Market Size, by Next-Generation Sequencing, 2017-2032 (USD Million)
TABLE 180. Africa Non-Invasive Prenatal DNA Testing Service Market Size, by Service Model, 2017-2032 (USD Million)
TABLE 181. Africa Non-Invasive Prenatal DNA Testing Service Market Size, by Centralized, 2017-2032 (USD Million)
TABLE 182. Africa Non-Invasive Prenatal DNA Testing Service Market Size, by Decentralized, 2017-2032 (USD Million)
TABLE 183. Africa Non-Invasive Prenatal DNA Testing Service Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 184. Africa Non-Invasive Prenatal DNA Testing Service Market Size, by Application, 2017-2032 (USD Million)
TABLE 185. Africa Non-Invasive Prenatal DNA Testing Service Market Size, by Microdeletion Syndrome, 2017-2032 (USD Million)
TABLE 186. Africa Non-Invasive Prenatal DNA Testing Service Market Size, by Sex Chromosome Abnormality, 2017-2032 (USD Million)
TABLE 187. Africa Non-Invasive Prenatal DNA Testing Service Market Size, by Trisomy Detection, 2017-2032 (USD Million)
TABLE 188. Africa Non-Invasive Prenatal DNA Testing Service Market Size, by End User, 2017-2032 (USD Million)
TABLE 189. Global Non-Invasive Prenatal DNA Testing Service Market Size, by Group, 2017-2032 (USD Million)
TABLE 190. ASEAN Non-Invasive Prenatal DNA Testing Service Market Size, by Group, 2017-2032 (USD Million)
TABLE 191. ASEAN Non-Invasive Prenatal DNA Testing Service Market Size, by Technology, 2017-2032 (USD Million)
TABLE 192. ASEAN Non-Invasive Prenatal DNA Testing Service Market Size, by Digital PCR, 2017-2032 (USD Million)
TABLE 193. ASEAN Non-Invasive Prenatal DNA Testing Service Market Size, by Microarray, 2017-2032 (USD Million)
TABLE 194. ASEAN Non-Invasive Prenatal DNA Testing Service Market Size, by Next-Generation Sequencing, 2017-2032 (USD Million)
TABLE 195. ASEAN Non-Invasive Prenatal DNA Testing Service Market Size, by Service Model, 2017-2032 (USD Million)
TABLE 196. ASEAN Non-Invasive Prenatal DNA Testing Service Market Size, by Centralized, 2017-2032 (USD Million)
TABLE 197. ASEAN Non-Invasive Prenatal DNA Testing Service Market Size, by Decentralized, 2017-2032 (USD Million)
TABLE 198. ASEAN Non-Invasive Prenatal DNA Testing Service Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 199. ASEAN Non-Invasive Prenatal DNA Testing Service Market Size, by Application, 2017-2032 (USD Million)
TABLE 200. ASEAN Non-Invasive Prenatal DNA Testing Service Market Size, by Microdeletion Syndrome, 2017-2032 (USD Million)
TABLE 201. ASEAN Non-Invasive Prenatal DNA Testing Service Market Size, by Sex Chromosome Abnormality, 2017-2032 (USD Million)
TABLE 202. ASEAN Non-Invasive Prenatal DNA Testing Service Market Size, by Trisomy Detection, 2017-2032 (USD Million)
TABLE 203. ASEAN Non-Invasive Prenatal DNA Testing Service Market Size, by End User, 2017-2032 (USD Million)
TABLE 204. GCC Non-Invasive Prenatal DNA Testing Service Market Size, by Group, 2017-2032 (USD Million)
TABLE 205. GCC Non-Invasive Prenatal DNA Testing Service Market Size, by Technology, 2017-2032 (USD Million)
TABLE 206. GCC Non-Invasive Prenatal DNA Testing Service Market Size, by Digital PCR, 2017-2032 (USD Million)
TABLE 207. GCC Non-Invasive Prenatal DNA Testing Service Market Size, by Microarray, 2017-2032 (USD Million)
TABLE 208. GCC Non-Invasive Prenatal DNA Testing Service Market Size, by Next-Generation Sequencing, 2017-2032 (USD Million)
TABLE 209. GCC Non-Invasive Prenatal DNA Testing Service Market Size, by Service Model, 2017-2032 (USD Million)
TABLE 210. GCC Non-Invasive Prenatal DNA Testing Service Market Size, by Centralized, 2017-2032 (USD Million)
TABLE 211. GCC Non-Invasive Prenatal DNA Testing Service Market Size, by Decentralized, 2017-2032 (USD Million)
TABLE 212. GCC Non-Invasive Prenatal DNA Testing Service Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 213. GCC Non-Invasive Prenatal DNA Testing Service Market Size, by Application, 2017-2032 (USD Million)
TABLE 214. GCC Non-Invasive Prenatal DNA Testing Service Market Size, by Microdeletion Syndrome, 2017-2032 (USD Million)
TABLE 215. GCC Non-Invasive Prenatal DNA Testing Service Market Size, by Sex Chromosome Abnormality, 2017-2032 (USD Million)
TABLE 216. GCC Non-Invasive Prenatal DNA Testing Service Market Size, by Trisomy Detection, 2017-2032 (USD Million)
TABLE 217. GCC Non-Invasive Prenatal DNA Testing Service Market Size, by End User, 2017-2032 (USD Million)
TABLE 218. European Union Non-Invasive Prenatal DNA Testing Service Market Size, by Group, 2017-2032 (USD Million)
TABLE 219. European Union Non-Invasive Prenatal DNA Testing Service Market Size, by Technology, 2017-2032 (USD Million)
TABLE 220. European Union Non-Invasive Prenatal DNA Testing Service Market Size, by Digital PCR, 2017-2032 (USD Million)
TABLE 221. European Union Non-Invasive Prenatal DNA Testing Service Market Size, by Microarray, 2017-2032 (USD Million)
TABLE 222. European Union Non-Invasive Prenatal DNA Testing Service Market Size, by Next-Generation Sequencing, 2017-2032 (USD Million)
TABLE 223. European Union Non-Invasive Prenatal DNA Testing Service Market Size, by Service Model, 2017-2032 (USD Million)
TABLE 224. European Union Non-Invasive Prenatal DNA Testing Service Market Size, by Centralized, 2017-2032 (USD Million)
TABLE 225. European Union Non-Invasive Prenatal DNA Testing Service Market Size, by Decentralized, 2017-2032 (USD Million)
TABLE 226. European Union Non-Invasive Prenatal DNA Testing Service Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 227. European Union Non-Invasive Prenatal DNA Testing Service Market Size, by Application, 2017-2032 (USD Million)
TABLE 228. European Union Non-Invasive Prenatal DNA Testing Service Market Size, by Microdeletion Syndrome, 2017-2032 (USD Million)
TABLE 229. European Union Non-Invasive Prenatal DNA Testing Service Market Size, by Sex Chromosome Abnormality, 2017-2032 (USD Million)
TABLE 230. European Union Non-Invasive Prenatal DNA Testing Service Market Size, by Trisomy Detection, 2017-2032 (USD Million)
TABLE 231. European Union Non-Invasive Prenatal DNA Testing Service Market Size, by End User, 2017-2032 (USD Million)
TABLE 232. BRICS Non-Invasive Prenatal DNA Testing Service Market Size, by Group, 2017-2032 (USD Million)
TABLE 233. BRICS Non-Invasive Prenatal DNA Testing Service Market Size, by Technology, 2017-2032 (USD Million)
TABLE 234. BRICS Non-Invasive Prenatal DNA Testing Service Market Size, by Digital PCR, 2017-2032 (USD Million)
TABLE 235. BRICS Non-Invasive Prenatal DNA Testing Service Market Size, by Microarray, 2017-2032 (USD Million)
TABLE 236. BRICS Non-Invasive Prenatal DNA Testing Service Market Size, by Next-Generation Sequencing, 2017-2032 (USD Million)
TABLE 237. BRICS Non-Invasive Prenatal DNA Testing Service Market Size, by Service Model, 2017-2032 (USD Million)
TABLE 238. BRICS Non-Invasive Prenatal DNA Testing Service Market Size, by Centralized, 2017-2032 (USD Million)
TABLE 239. BRICS Non-Invasive Prenatal DNA Testing Service Market Size, by Decentralized, 2017-2032 (USD Million)
TABLE 240. BRICS Non-Invasive Prenatal DNA Testing Service Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 241. BRICS Non-Invasive Prenatal DNA Testing Service Market Size, by Application, 2017-2032 (USD Million)
TABLE 242. BRICS Non-Invasive Prenatal DNA Testing Service Market Size, by Microdeletion Syndrome, 2017-2032 (USD Million)
TABLE 243. BRICS Non-Invasive Prenatal DNA Testing Service Market Size, by Sex Chromosome Abnormality, 2017-2032 (USD Million)
TABLE 244. BRICS Non-Invasive Prenatal DNA Testing Service Market Size, by Trisomy Detection, 2017-2032 (USD Million)
TABLE 245. BRICS Non-Invasive Prenatal DNA Testing Service Market Size, by End User, 2017-2032 (USD Million)
TABLE 246. G7 Non-Invasive Prenatal DNA Testing Service Market Size, by Group, 2017-2032 (USD Million)
TABLE 247. G7 Non-Invasive Prenatal DNA Testing Service Market Size, by Technology, 2017-2032 (USD Million)
TABLE 248. G7 Non-Invasive Prenatal DNA Testing Service Market Size, by Digital PCR, 2017-2032 (USD Million)
TABLE 249. G7 Non-Invasive Prenatal DNA Testing Service Market Size, by Microarray, 2017-2032 (USD Million)
TABLE 250. G7 Non-Invasive Prenatal DNA Testing Service Market Size, by Next-Generation Sequencing, 2017-2032 (USD Million)
TABLE 251. G7 Non-Invasive Prenatal DNA Testing Service Market Size, by Service Model, 2017-2032 (USD Million)
TABLE 252. G7 Non-Invasive Prenatal DNA Testing Service Market Size, by Centralized, 2017-2032 (USD Million)
TABLE 253. G7 Non-Invasive Prenatal DNA Testing Service Market Size, by Decentralized, 2017-2032 (USD Million)
TABLE 254. G7 Non-Invasive Prenatal DNA Testing Service Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 255. G7 Non-Invasive Prenatal DNA Testing Service Market Size, by Application, 2017-2032 (USD Million)
TABLE 256. G7 Non-Invasive Prenatal DNA Testing Service Market Size, by Microdeletion Syndrome, 2017-2032 (USD Million)
TABLE 257. G7 Non-Invasive Prenatal DNA Testing Service Market Size, by Sex Chromosome Abnormality, 2017-2032 (USD Million)
TABLE 258. G7 Non-Invasive Prenatal DNA Testing Service Market Size, by Trisomy Detection, 2017-2032 (USD Million)
TABLE 259. G7 Non-Invasive Prenatal DNA Testing Service Market Size, by End User, 2017-2032 (USD Million)
TABLE 260. NATO Non-Invasive Prenatal DNA Testing Service Market Size, by Group, 2017-2032 (USD Million)
TABLE 261. NATO Non-Invasive Prenatal DNA Testing Service Market Size, by Technology, 2017-2032 (USD Million)
TABLE 262. NATO Non-Invasive Prenatal DNA Testing Service Market Size, by Digital PCR, 2017-2032 (USD Million)
TABLE 263. NATO Non-Invasive Prenatal DNA Testing Service Market Size, by Microarray, 2017-2032 (USD Million)
TABLE 264. NATO Non-Invasive Prenatal DNA Testing Service Market Size, by Next-Generation Sequencing, 2017-2032 (USD Million)
TABLE 265. NATO Non-Invasive Prenatal DNA Testing Service Market Size, by Service Model, 2017-2032 (USD Million)
TABLE 266. NATO Non-Invasive Prenatal DNA Testing Service Market Size, by Centralized, 2017-2032 (USD Million)
TABLE 267. NATO Non-Invasive Prenatal DNA Testing Service Market Size, by Decentralized, 2017-2032 (USD Million)
TABLE 268. NATO Non-Invasive Prenatal DNA Testing Service Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 269. NATO Non-Invasive Prenatal DNA Testing Service Market Size, by Application, 2017-2032 (USD Million)
TABLE 270. NATO Non-Invasive Prenatal DNA Testing Service Market Size, by Microdeletion Syndrome, 2017-2032 (USD Million)
TABLE 271. NATO Non-Invasive Prenatal DNA Testing Service Market Size, by Sex Chromosome Abnormality, 2017-2032 (USD Million)
TABLE 272. NATO Non-Invasive Prenatal DNA Testing Service Market Size, by Trisomy Detection, 2017-2032 (USD Million)
TABLE 273. NATO Non-Invasive Prenatal DNA Testing Service Market Size, by End User, 2017-2032 (USD Million)
TABLE 274. Global Non-Invasive Prenatal DNA Testing Service Market Size, by Country, 2017-2032 (USD Million)
TABLE 275. United States Non-Invasive Prenatal DNA Testing Service Market Size, 2017-2032 (USD Million)
TABLE 276. United States Non-Invasive Prenatal DNA Testing Service Market Size, by Technology, 2017-2032 (USD Million)
TABLE 277. United States Non-Invasive Prenatal DNA Testing Service Market Size, by Digital PCR, 2017-2032 (USD Million)
TABLE 278. United States Non-Invasive Prenatal DNA Testing Service Market Size, by Microarray, 2017-2032 (USD Million)
TABLE 279. United States Non-Invasive Prenatal DNA Testing Service Market Size, by Next-Generation Sequencing, 2017-2032 (USD Million)
TABLE 280. United States Non-Invasive Prenatal DNA Testing Service Market Size, by Service Model, 2017-2032 (USD Million)
TABLE 281. United States Non-Invasive Prenatal DNA Testing Service Market Size, by Centralized, 2017-2032 (USD Million)
TABLE 282. United States Non-Invasive Prenatal DNA Testing Service Market Size, by Decentralized, 2017-2032 (USD Million)
TABLE 283. United States Non-Invasive Prenatal DNA Testing Service Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 284. United States Non-Invasive Prenatal DNA Testing Service Market Size, by Application, 2017-2032 (USD Million)
TABLE 285. United States Non-Invasive Prenatal DNA Testing Service Market Size, by Microdeletion Syndrome, 2017-2032 (USD Million)
TABLE 286. United States Non-Invasive Prenatal DNA Testing Service Market Size, by Sex Chromosome Abnormality, 2017-2032 (USD Million)
TABLE 287. United States Non-Invasive Prenatal DNA Testing Service Market Size, by Trisomy Detection, 2017-2032 (USD Million)
TABLE 288. United States Non-Invasive Prenatal DNA Testing Service Market Size, by End User, 2017-2032 (USD Million)
TABLE 289. Canada Non-Invasive Prenatal DNA Testing Service Market Size, 2017-2032 (USD Million)
TABLE 290. Canada Non-Invasive Prenatal DNA Testing Service Market Size, by Technology, 2017-2032 (USD Million)
TABLE 291. Canada Non-Invasive Prenatal DNA Testing Service Market Size, by Digital PCR, 2017-2032 (USD Million)
TABLE 292. Canada Non-Invasive Prenatal DNA Testing Service Market Size, by Microarray, 2017-2032 (USD Million)
TABLE 293. Canada Non-Invasive Prenatal DNA Testing Service Market Size, by Next-Generation Sequencing, 2017-2032 (USD Million)
TABLE 294. Canada Non-Invasive Prenatal DNA Testing Service Market Size, by Service Model, 2017-2032 (USD Million)
TABLE 295. Canada Non-Invasive Prenatal DNA Testing Service Market Size, by Centralized, 2017-2032 (USD Million)
TABLE 296. Canada Non-Invasive Prenatal DNA Testing Service Market Size, by Decentralized, 2017-2032 (USD Million)
TABLE 297. Canada Non-Invasive Prenatal DNA Testing Service Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 298. Canada Non-Invasive Prenatal DNA Testing Service Market Size, by Application, 2017-2032 (USD Million)
TABLE 299. Canada Non-Invasive Prenatal DNA Testing Service Market Size, by Microdeletion Syndrome, 2017-2032 (USD Million)
TABLE 300. Canada Non-Invasive Prenatal DNA Testing Service Market Size, by Sex Chromosome Abnormality, 2017-2032 (USD Million)
TABLE 301. Canada Non-Invasive Prenatal DNA Testing Service Market Size, by Trisomy Detection, 2017-2032 (USD Million)
TABLE 302. Canada Non-Invasive Prenatal DNA Testing Service Market Size, by End User, 2017-2032 (USD Million)
TABLE 303. Mexico Non-Invasive Prenatal DNA Testing Service Market Size, 2017-2032 (USD Million)
TABLE 304. Mexico Non-Invasive Prenatal DNA Testing Service Market Size, by Technology, 2017-2032 (USD Million)
TABLE 305. Mexico Non-Invasive Prenatal DNA Testing Service Market Size, by Digital PCR, 2017-2032 (USD Million)
TABLE 306. Mexico Non-Invasive Prenatal DNA Testing Service Market Size, by Microarray, 2017-2032 (USD Million)
TABLE 307. Mexico Non-Invasive Prenatal DNA Testing Service Market Size, by N

Companies Mentioned

  • Agile Bio
  • ARUP Laboratories, LLC
  • Bio-Reference Laboratories, Inc.
  • Biora Labs Pvt. Ltd.
  • BMLabs
  • Centogene N.V.
  • Cohesion Healthcare Services, Inc.
  • Eurofins LifeCodexx GmbH
  • Freenome Holdings, Inc.
  • Fulgent Genetics, Inc.
  • Genedia Co., Ltd.
  • GenePlanet d.o.o.
  • Genetics Institute, LLC
  • Genoma S.A.
  • Health Network Laboratories, Inc.
  • Illumina, Inc.
  • Integrated Genetics, LLC
  • Invitae Corporation
  • Laboratory Corporation of America Holdings
  • Natera, Inc.
  • PerkinElmer, Inc.
  • Progenity, Inc.
  • Quest Diagnostics Incorporated
  • Roche Holding AG
  • Sema4, Inc.
  • Shenzhen BGI Gene-Tech Co., Ltd.
  • Sonic Healthcare Limited
  • Thermo Fisher Scientific Inc.
  • Trivitron Healthcare Pvt. Ltd.
  • Yourgene Health plc

Related Topics

Related Reports

Non-invasive Prenatal Testing Market - Global Forecast 2026-2032 - Product Image

Non-invasive Prenatal Testing Market - Global Forecast 2026-2032

  • Report
  • 198 Pages
  • Global
From
Non-invasive Prenatal Genetic Testing Market - Global Forecast 2026-2032 - Product Image

Non-invasive Prenatal Genetic Testing Market - Global Forecast 2026-2032

  • Report
  • 196 Pages
  • Global
From
Non-Invasive Prenatal Testing Market (By Product, Gestation Period, Pregnancy Risk, Technology, Application, End User, and Region), Key Company Profiles, Market Dynamics, Trends and Recent Developments - Global Forecast to 2032 - Product Image

Non-Invasive Prenatal Testing Market (By Product, Gestation Period, Pregnancy Risk, Technology, Application, End User, and Region), Key Company Profiles, Market Dynamics, Trends and Recent Developments - Global Forecast to 2032

  • Report
  • Global
From
Non-Invasive Prenatal Testing (NIPT) - Global Strategic Business Report - Product Image

Non-Invasive Prenatal Testing (NIPT) - Global Strategic Business Report

  • Report
  • 456 Pages
  • Global
From
Non-Invasive Prenatal Testing (NIPT) Market - Strategic Insights and Forecasts (2026-2035) - Product Image

Non-Invasive Prenatal Testing (NIPT) Market - Strategic Insights and Forecasts (2026-2035)

  • Report
  • 174 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.